Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulation of Clot Structure and Platelet Function by Aspirin in Individuals with Type 1 Diabetes Mellitus
2008-007875-26Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in diabetes mellitus type 1 (T1D), sponsored by University of Leeds. Primary endpoints: Prevalence of aspirin resistance in patients with type 1 diabetes mellitus and Mechanisms of aspirin resistance. Started Jul 2009; status: completed.
02
Drugs
aspirin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2008-007875-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007875-26.